Piera Capranzano

Catania, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 194 publications

Pretreatment with P2Y12 inhibitors in Acute and Chronic Coronary Syndromes: for whom, when and how.

Pretreatment with P2Y12 inhibitors in Acute and Chronic Coronary Syndromes: for whom, when and how.

Journal: The American journal of medicine

Published: August 10, 2026

Metabolic Dysfunction-Associated Steatotic Liver Disease: An Underrated and Emerging Cardiovascular Risk Factor.

Metabolic Dysfunction-Associated Steatotic Liver Disease: An Underrated and Emerging Cardiovascular Risk Factor.

Journal: Anatolian journal of cardiology

Published: July 27, 2026

Discontinuation of anticoagulation therapy after atrial fibrillation ablation: the ALONE-AF and OCEAN studies.

Discontinuation of anticoagulation therapy after atrial fibrillation ablation: the ALONE-AF and OCEAN studies.

Journal: European heart journal supplements : journal of the European Society of Cardiology

Published: May 08, 2026

Percutaneous coronary intervention in high-bleeding risk patients: a review of contemporary management strategies.

Percutaneous coronary intervention in high-bleeding risk patients: a review of contemporary management strategies.

Journal: Expert review of cardiovascular therapy

Published: March 19, 2026

Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented Strategies.

Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented Strategies.

Journal: Journal of clinical medicine

Published: February 19, 2026

Use of cangrelor in patients with reduced renal function: Post-hoc analysis from the ARCANGELO study.

Use of cangrelor in patients with reduced renal function: Post-hoc analysis from the ARCANGELO study.

Journal: International journal of cardiology

Published: February 19, 2026

Eligibility for dual pathway inhibition in patients with peripheral artery disease undergoing revascularization.

Eligibility for dual pathway inhibition in patients with peripheral artery disease undergoing revascularization.

Journal: Journal of cardiovascular medicine (Hagerstown, Md.)

Published: September 27, 2025

Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.

Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.

Journal: Lancet (London, England)

Published: September 25, 2025

Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.

Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: May 19, 2025

Should MitraClip also be used in less severe functional mitral regurgitation? The RESHAPE-HF2 study.

Should MitraClip also be used in less severe functional mitral regurgitation? The RESHAPE-HF2 study.

Journal: European heart journal supplements : journal of the European Society of Cardiology

Published: April 18, 2025

Clinical feasibility of a quick response code-based digital self-reporting of medication adherence: results in patients on ticagrelor therapy from the APOLLO-QR observational study.

Clinical feasibility of a quick response code-based digital self-reporting of medication adherence: results in patients on ticagrelor therapy from the APOLLO-QR observational study.

Journal: European heart journal. Digital health

Published: November 13, 2024

Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.

Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.

Journal: European heart journal

Published: September 23, 2024

Showing 1-12 of 194

Last Updated: 09/26/2026